Key Highlights
- Shares of Aehr Test Systems climbed 15.41% Thursday following the reveal of a historic $41 million production contract from a hyperscale client.
- The contract involves package-level burn-in services for custom AI processor ASICs utilizing Aehr’s Sonoma high-power testing platforms.
- Shipments are scheduled to commence in fiscal 2027, beginning June 27, 2026.
- One day prior to the public announcement, a company director offloaded $1.21 million worth of shares on April 16.
- Analyst sentiment remains overwhelmingly bullish with a Strong Buy rating and a $62 average target price.
Aehr Test Systems secured what marks its largest-ever contract on Thursday, triggering significant investor enthusiasm. The semiconductor test equipment manufacturer revealed a $41 million production agreement with its primary hyperscale client for package-level burn-in testing of proprietary AI processor ASICs. AEHR stock rocketed 15.41% following the disclosure.
The contract encompasses a substantial quantity of Aehr’s Sonoma high-power package-level testing and burn-in platforms. Additionally, it incorporates turnkey burn-in modules along with device-specific sockets designed to customize the systems for particular AI processors.
This represents a continuation order, indicating the hyperscale client — whose name remains undisclosed — maintains an established working relationship with Aehr. The agreement reinforces an already expanding partnership between the two entities.
Shipments are scheduled to commence during Aehr’s fiscal 2027, which begins on June 27, 2026. This timeline provides the company with predictable near-term revenue visibility.
Chief Executive Gayn Erickson emphasized this contract represents only the beginning of opportunities ahead. He highlighted that the client is simultaneously engineering a next-generation, higher-power AI accelerator ASIC anticipated to enter production within the current year.
Aehr has already secured an initial purchase order from this identical customer for multiple Sonoma platforms to facilitate production of the advanced device. This suggests the $41 million agreement may represent merely the first installment of expanded future demand.
“As these next-generation devices move into volume production, we see the potential for further substantial increases in demand for Sonoma systems and consumables in our next fiscal year,” Erickson said.
Impressive Performance Leading Up to the News
Thursday’s price action amplifies what has been an extraordinary trajectory for AEHR. Year-to-date, the stock has surged 246.95%, while delivering a staggering 805.07% return over the trailing twelve months.
Trading volume reached over 1.75 million AEHR shares during the session, approaching the three-month daily average of approximately 2.77 million shares.
The historic contract announcement also follows solid fiscal Q3 2026 performance. Revenue totaled $10.3 million, marginally below the anticipated $10.8 million, yet the company achieved record quarterly bookings of $37.2 million. This robust booking activity elevated its order backlog beyond $50 million.
Regarding earnings per share, Aehr exceeded projections — delivering -$0.05 compared to the consensus estimate of -$0.07.
Wall Street and Insider Movements
Analyst community has been revising price objectives upward. Freedom Broker increased its target to $61 from $38 while retaining a Hold rating. Lake Street elevated its target to $56 from $50, pointing to robust booking trends, and maintained its Buy recommendation.
The prevailing Wall Street consensus stands at Strong Buy, featuring three Buy ratings issued within the past three months. The mean price target rests at $62, suggesting approximately 26.67% potential appreciation from present levels.
Regarding insider transactions, Director Rhea J. Posedel divested 15,000 shares on April 16 at $80.72 each, generating $1.21 million in proceeds. Post-transaction, Posedel maintains direct ownership of 71,163 shares, along with 411,979 shares held indirectly via a trust arrangement.
